Aspirin to help prevent pregnancy complications after IVF
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This Phase 3 study tests whether daily low-dose aspirin can reduce the risk of preeclampsia (dangerous high blood pressure in pregnancy) and improve pregnancy outcomes for people who got pregnant using assisted reproduction like IVF. It mainly targets pregnancies early on (about 9–14 weeks).
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and having your first pregnancy
- Be pregnant after assisted reproduction (like IVF/ICSI, egg donation, or donor sperm insemination)
- Be carrying one baby and be between 9 and 14 weeks pregnant
- Be covered by French social security or an equivalent health protection plan
- Sign consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a daily low-dose aspirin can help prevent pregnancy loss and preeclampsia. It's for women who are in early pregnancy and have certain health risks.
This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.
This trial tests whether women at high risk for preeclampsia can safely stop taking aspirin after 24-28 weeks if their blood test shows a low risk. It aims to avoid unnecessary medication while protecting both mother and baby.
This trial tests whether taking baby-dose aspirin after a frozen embryo transfer can lower the chance of developing pre-eclampsia, a blood-pressure problem that can happen during pregnancy. It targets women considered at higher risk based on specific health factors and pregnancy details.
This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.
This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.
Hear when a new ART trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.